๐งช API Manufacturing Mergers & Acquisitions: Strategic Growth, Capacity Expansion & Global Market Power
๐ญ API Manufacturing Mergers & Acquisitions ________________________________________ ๐งช API Manufacturing Mergers & Acquisitions: Strategic Growth, Capacity Expansion & Global Market Power ๐ Introduction The Active Pharmaceutical Ingredient (API) manufacturing industry is entering a period of rapid consolidation. As pharmaceutical demand grows, companies are increasingly turning to mergers & acquisitions (M&A) to expand production capacity, access new technologies, strengthen supply chains, and enter new markets. For companies like Swapnroop Drugs and Pharmaceuticals, understanding M&A dynamics is essential to remain competitive, compliant, and future-ready in a globalized pharmaceutical ecosystem. M&A is no longer just about buying assets — it is about building integrated pharmaceutical manufacturing platforms capable of serving global drug innovators. ________________________________________ ๐ Why Mergers & Acquisitions Are Rising in API Manu...